Exploiting Tissue Sparing E3 Ligases for Next Generation TPD Medicines
Time: 8:00 am
day: Day 2 AM
Details:
- Highlighting the promises and challenges of exploiting tissue sparing E3 ligases
- Pinpointing LED selection criteria for novel E3 ligases for TPD application
- Showcasing tissue sparing E3 ligases to unlock clinically validated targets
